Devyser has secured a CFTR NGS proposal with UNC Hospitals. The proposal with UNC Hospitals is...
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
“Devyser is able to report strong sales growth and record high gross margins for the fourth...
Devyser Genomic Laboratories, Devyser's US-based CLIA-certified laboratory, has signed its first...
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser Diagnostics AB has entered an in vitro diagnostic development agreement with Illumina, Inc....
Devyser has been awarded a tender for Devyser’s CFTR fragment analysis products, that are used for...
Devyser has been awarded a tender for Devyser RHD, its product for non-invasive fetal RHD status in...
“Devyser is reporting record sales growth (+50% organic growth) for the third quarter, a further...
Dear Devyser network, partners, and valued customers,
Devyser and Thermo Fisher Scientific have entered into a collaboration agreement to promote...
